| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |